journal article·2019-01

Wnt and Notch signaling pathways in calcium phosphate‐enhanced osteogenic differentiation: A pilot study

Yu Wang, Jianwei Pan, Yiqun Zhang, Xiang Li, Zhen Zhang, Peng Wang, Zhifan Qin, Jihua Li

Publisher page

Abstract

Abstract Calcium phosphate (CaP) ceramics are being increasingly used to repair critical bone defect for biocompatibility, biosafety, porous structure and osteoinduction. Wnt and Notch signaling pathways are conservative and classic signaling pathways regulating osteogenic differentiation of bone marrow mesenchymal stromal cells (BMSCs). In this study, we evaluated the expression of Wnt, Notch signal pathways and osteogenic related genes of BMSCs with and without Wnt pathway inhibitor DKK1 on CaP ceramics in vitro by real‐time RT‐PCR. Also, we evaluated new bone formation after implantation of CaP ceramics in vivo. The in vitro culture displayed the expression of Wnt, Notch signaling pathways and osteogenic related genes was increased at first and then declined. After adding DKK1 to the culture, the expression was decreased. The in vivo implantation showed significant bone formation on CaP ceramics. These findings reveal that Wnt and Notch signaling pathways play important roles in the CaP‐enhanced osteogenic differentiation but the mechanism of synergistic effect needs to be further explored. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 107B: 149–160, 2019.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Other Research, Platforms & Department of Oral and Maxillofacial Surgery, West China College of Stomatology Sichuan University Chengdu 610041 China

Funding

National Natural Science Foundation of China

References (44)

Show source-provided references
1. 10.22203/eCM.v021a3110.22203/eCM.v021a31 ↗
2. 10.1016/j.biomaterials.2004.09.05610.1016/j.biomaterials.2004.09.056 ↗
3. 10.1002/jbm.a.3527210.1002/jbm.a.35272 ↗
4. 10.1016/j.actbio.2014.03.02110.1016/j.actbio.2014.03.021 ↗
5. . Hydoxyapatite/beta‐tricalcium phosphate biphasic ceramics as regenerative material for the repair of complex bone defects
6. 10.1016/0142-9612(96)80752-610.1016/0142-9612(96)80752-6 ↗
7. 10.1016/j.msec.2012.12.02310.1016/j.msec.2012.12.023 ↗
8. 10.1073/pnas.100360010710.1073/pnas.1003600107 ↗
9. 10.1016/S0142-9612(01)00119-310.1016/S0142-9612(01)00119-3 ↗
10. 10.1002/jcb.2328710.1002/jcb.23287 ↗
11. 10.1016/S0092-8674(00)80257-310.1016/S0092-8674(00)80257-3 ↗
12. 10.1016/S0092-8674(00)80258-510.1016/S0092-8674(00)80258-5 ↗
13. 10.1038/boneres.2015.510.1038/boneres.2015.5 ↗
14. 10.1126/scitranslmed.300023110.1126/scitranslmed.3000231 ↗
15. 10.4161/org.4.2.585110.4161/org.4.2.5851 ↗
16. 10.1242/jcs.0282610.1242/jcs.02826 ↗
17. 10.1074/jbc.M50060820010.1074/jbc.M500608200 ↗
18. 10.1074/jbc.M70003020010.1074/jbc.M700030200 ↗
19. Wnt3a enhances bone morphogenetic protein 9‐induced osteogenic differentiation of c3h10t1/2 cells
20. 10.1002/jbmr.219810.1002/jbmr.2198 ↗
21. 10.1016/j.bone.2009.05.02710.1016/j.bone.2009.05.027 ↗
22. 10.1210/er.2006-004610.1210/er.2006-0046 ↗
23. 10.1038/nm171210.1038/nm1712 ↗
24. 10.1074/jbc.M50837020010.1074/jbc.M508370200 ↗
25. 10.1038/nrm304910.1038/nrm3049 ↗
26. 10.1002/jbm.a.3524210.1002/jbm.a.35242 ↗
27. A clinically relevant model of osteoinduction: A process requiring calcium phosphate and bmp/wnt signalling10.1111/j.1582-4934.2009.00807.x ↗
28. 10.1002/jcb.2109710.1002/jcb.21097 ↗
29. 10.1007/s00018-008-8042-110.1007/s00018-008-8042-1 ↗
30. 10.1359/jbmr.07072110.1359/jbmr.070721 ↗
31. 10.1038/nm.238810.1038/nm.2388 ↗
32. 10.2147/IJN.S9034310.2147/IJN.S90343 ↗
33. 10.1186/s13287-017-0588-010.1186/s13287-017-0588-0 ↗
34. 10.1111/clr.1217810.1111/clr.12178 ↗
35. 10.1182/blood-2002-06-174010.1182/blood-2002-06-1740 ↗
36. 10.1111/j.1582-4934.2008.00569.x10.1111/j.1582-4934.2008.00569.x ↗
37. 10.1074/jbc.M80638920010.1074/jbc.M806389200 ↗
38. 10.18632/oncotarget.1865510.18632/oncotarget.18655 ↗
39. 10.1074/jbc.M40381320010.1074/jbc.M403813200 ↗
40. Intermittent activation of notch signaling promotes bone formation
41. 10.1242/jcs.12730810.1242/jcs.127308 ↗
42. 10.1128/MCB.25.12.4946-4955.200510.1128/MCB.25.12.4946-4955.2005 ↗
43. 10.1056/NEJMoa03084710.1056/NEJMoa030847 ↗
44. 10.1359/jbmr.06031110.1359/jbmr.060311 ↗